Antibiotics for Bronchitis and Wheezing
Antibiotics are NOT indicated for acute bronchitis with wheezing in otherwise healthy adults, as more than 90% of cases are viral and antibiotics provide no meaningful clinical benefit. 1, 2
General Population: Acute Bronchitis with Wheezing
Do not prescribe antibiotics for uncomplicated acute bronchitis. The evidence is clear:
- Routine antibiotic treatment does not reduce duration or severity of illness, regardless of cough duration 1
- Antibiotics shorten cough by only half a day while causing adverse effects including allergic reactions, gastrointestinal symptoms, and C. difficile infection 3
- More than 90% of acute bronchitis cases are viral; purulent (green or yellow) sputum does NOT indicate bacterial infection 1, 4
- The FDA removed acute bronchitis as an indication for antimicrobial therapy in 1998 1
For symptomatic relief of wheezing: Use albuterol (β-agonist), which reduces cough duration and severity in approximately 50% of patients by day 7 1. This addresses the bronchial hyperresponsiveness that causes wheezing without unnecessary antibiotic exposure.
High-Risk Populations Requiring Antibiotics
Chronic Obstructive Pulmonary Disease (COPD)
Prescribe antibiotics when at least 2 of 3 Anthonisen criteria are present: 2
- Increased sputum volume
- Increased sputum purulence
- Increased dyspnea
First-line: Amoxicillin or azithromycin 500 mg daily for 3 days 2, 5
Second-line (if first-line fails): Amoxicillin-clavulanate or respiratory fluoroquinolones (levofloxacin, moxifloxacin) 2
Severe COPD (FEV1 <35%)
Immediate antibiotic therapy is recommended during any exacerbation without waiting for Anthonisen criteria 2. These patients have chronic respiratory insufficiency and cannot tolerate delayed treatment.
Infants with Persistent/Recurrent Wheezing
This represents a fundamentally different clinical scenario than adult acute bronchitis:
Do NOT empirically prescribe antibiotics. Instead, perform flexible fiberoptic bronchoscopy with bronchoalveolar lavage (BAL) to identify bacterial infection before treating 1. Here's why:
- 40-60% of infants with persistent wheezing have positive BAL cultures 1
- Only 20-30% will improve with antibiotics after confirmed BAL-identified infection 1
- Empiric antibiotics mean 40-60% receive unnecessary treatment 1
- Bronchoscopy also identifies structural abnormalities (tracheomalacia, vascular rings) in 33% of cases, which require different management 1
When to consider bronchoscopy: Persistent wheezing despite treatment with bronchodilators, inhaled corticosteroids, or systemic corticosteroids 1
Common Pitfalls to Avoid
- Do not assume purulent sputum indicates bacterial infection - purulence reflects inflammatory cells, not bacteria 1
- Do not use "bronchitis" terminology with patients - call it a "chest cold" to reduce antibiotic expectations 1
- Do not prescribe fluoroquinolones (ciprofloxacin, ofloxacin) or cefixime - inadequate pneumococcal coverage 2
- Do not use cotrimoxazole - inconsistent pneumococcal activity and poor benefit/risk ratio 2
- Always rule out pneumonia - check for tachycardia (>100 bpm), tachypnea (>24 breaths/min), fever (>38°C), and abnormal chest exam findings 1
Patient Communication Strategy
Set realistic expectations: 1, 3
- Cough typically lasts 10-14 days after the visit (up to 3 weeks total)
- Explain that previous antibiotic use increases risk of resistant infections
- Discuss specific adverse effects: gastrointestinal symptoms, allergic reactions, rare serious complications
- Offer symptomatic treatment (albuterol for wheezing, dextromethorphan for cough)
Patient satisfaction depends on communication quality, not antibiotic prescription 1. Studies show that reducing antibiotic use does not increase return visits or patient dissatisfaction when proper education is provided 1.